Ian F. Smith, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 85,093 shares at $160.12 ($13.5M) on 2018-04-26, disclosed to the SEC on 2018-04-27.
Scheduled sale ($13.5M) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.98 | 19,478 | $3.0M | 22.4% |
| 2 | $155.62 | 9,790 | $1.5M | 11.3% |
| 3 | $156.78 | 2,700 | $423K | 3.1% |
| 4 | $160.12 | 53,125 | $8.5M | 63.1% |
| Total | $158.32 avg | 85,093 | $13.5M | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |